Umbilical Cord Blood, Stem Cells, and Bone Marrow Transplantation

2003 ◽  
pp. 47-60
Author(s):  
RONALD M. KLINE
2020 ◽  
Author(s):  
Zhi Huang ◽  
Yuhua Xiao ◽  
Xiaomin Chen ◽  
Huiping Li ◽  
Jingyu Gao ◽  
...  

Abstract Background: Iron overload aggravates the difficulty of umbilical cord blood stem cell engraftment and reduces the survival of patients undergoing hematopoietic stem cells (HSC) transplantation. Mesenchymal stem cells (MSC) have been implicated in playing a significant role in HSC engraftment. This study aimed to determine the effect of intra-bone marrow (IBM) co-transplantation of umbilical cord blood mononuclear cells (UCB-MNC) and mesenchymal stem cells (UC-MSC) on the engraftment and hematopoietic recovery in an iron overload hematopoietic microenvironment. Methods: The iron overload model was established by dose-escalation intraperitoneal injection of iron dextran in NOD/SCID mice. Iron deposition in the bone marrow, heart, and liver was examined using H&E staining. Serum levels of ferritin and iron status in the liver were measured. The iron overload NOD/SCID mice were sublethally irradiated and divided into four groups for transplantation: (1) control group, (2) IBM MSC+ group: IBM injection of combined UCB-MNC/UC-MSC, (3) IBM group: IBM injection of only UCB-MNC, and (4) IV group: intravenous injection of UCB-MNC. Six weeks after transplantation, the human CD45 + cells in the bone marrow were analyzed by flow cytometry. The semi-quantitative analysis of vascular endothelial growth factor (VEGF-a), osteopontin (OPN), and stromal cell-derived factor-1a (SDF-1a) were examined by immunohistochemistry staining (IHC). Results: The survival rate and the percentages of human CD45 + cells in bone marrow were highest in the IBM MSC+ group with statistical significance. In addition, the levels of VEGF-a, OPN, and SDF-1a in bone marrow were all significantly higher in the IBM MSC+ group than the other groups. Conclusion: IBM co-transplantation of UC-MSC might improve the engraftment of UCB-MNC in iron overload NOD/SCID mice. The increased expression of VEGF-a, OPN, and SDF-1a in the bone marrow may be involved in improving the hematopoietic microenvironment and promoting the implantation of human umbilical cord blood stem cells in the bone marrow with iron overload.


2016 ◽  
Vol 27 (2) ◽  
pp. 79-82
Author(s):  
N Yasmin ◽  
N Kabir ◽  
T Afrin ◽  
S Ahmed ◽  
K Khatun

Introduction: Umbilical cord blood is blood left over in the placenta and in the umbilical cord after the birth of the baby. Umbilical cord blood saving consists of the collection, processing and cryopreservation of the remaining blood within the umbilicus and placenta following the birth of a child. Within this left over blood, traditionally discarded with the placenta as medical waste, lies a rich source of haematopoietic stem cells same as bone marrow. Cord blood stem cells have advantages over bone marrow in transplants and have been used in more than 30,000 transplants to regenerate healthy blood and immune systems1. Today, stem cell therapies continue to evolve, bringing new hope to patients and their families.Objective: To aware regarding use of stem cells of baby’s umbilical cord blood in future.Methods: A review of relevant articles and documents and some world standard stem cell banking protocol were undertaken.Conclusion: When these cord blood stem cells are processed and stored, the cells are not only a perfect match for the baby, but it could also provide life saving benefits for siblings and other family members.Bangladesh J Obstet Gynaecol, 2012; Vol. 27(2) : 79-82


2013 ◽  
Vol 3 ◽  
pp. 399-402
Author(s):  
Katarzyna Pawelec ◽  
Dariusz Boruczkowski ◽  
Tomasz Oldak ◽  
Marek Ussowicz ◽  
Urszula Demkow ◽  
...  

2017 ◽  
Vol 83 (1-2) ◽  
pp. 205-213 ◽  
Author(s):  
Priya F Maillacheruvu ◽  
Lauren M Engel ◽  
Isaiah T Crum ◽  
Devendra K Agrawal ◽  
Eric S Peeples

Sign in / Sign up

Export Citation Format

Share Document